File(s) under permanent embargo
Advanced drug delivery systems can assist in targeting coronavirus disease (COVID-19): A hypothesis
journal contribution
posted on 2023-05-21, 10:20 authored by Mehta, M, Prasher, P, Sharma, M, Madhur ShastriMadhur Shastri, Khurana, N, Vyas, M, Dureja, H, Gupta, G, Anand, K, Satija, S, Chellappan, DK, Dua, KThe highly contagious coronavirus, which had already affected more than 2 million people in 210 countries, triggered a colossal economic crisis consequently resulting from measures adopted by various goverments to limit transmission. This has placed the lives of many people infected worldwide at great risk. Currently there are no established or validated treatments for COVID-19, that is approved worldwide. Nanocarriers may offer a wide range of applications that could be developed into risk-free approaches for successful therapeutic strategies that may lead to immunisation against the severe acute respiratory syndrome coronavirus 2 (SARS‑CoV‑2) which is the primary causative organism that had led to the current COVID-19 pandemic. We address existing as well as emerging therapeutic and prophylactic approaches that may enable us to effectively combat this pandemic, and also may help to identify the key areas where nano-scientists can step in.
History
Publication title
Medical HypothesesVolume
144Pagination
1-5ISSN
0306-9877Department/School
School of Pharmacy and PharmacologyPublisher
Eden PressPlace of publication
United StatesRights statement
© 2020 Elsevier Ltd. All rights reserved.Repository Status
- Restricted